Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection
Tuberculosis (TB) is the leading infectious cause of mortality worldwide, due in part to a
limited understanding of its clinical pathogenic spectrum of infection and disease …
limited understanding of its clinical pathogenic spectrum of infection and disease …
From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning
LS Li, L Yang, L Zhuang, ZY Ye, WG Zhao… - Military Medical …, 2023 - Springer
Latent tuberculosis infection (LTBI) has become a major source of active tuberculosis (ATB).
Although the tuberculin skin test and interferon-gamma release assay can be used to …
Although the tuberculin skin test and interferon-gamma release assay can be used to …
Risk of tuberculosis reactivation in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis receiving non‐anti‐TNF‐targeted biologics
F Cantini, C Nannini, L Niccoli, L Petrone… - Mediators of …, 2017 - Wiley Online Library
Tuberculosis (TB) still represents an important issue for public health in underdeveloped
countries, but the use of antitumor necrosis factor agents (anti‐TNF) for the treatment of …
countries, but the use of antitumor necrosis factor agents (anti‐TNF) for the treatment of …
Fourth-generation QuantiFERON-TB Gold Plus: what is the evidence?
ABSTRACT QuantiFERON-TB Gold Plus (QFT-Plus) is the latest generation of interferon
gamma release assays (IGRAs) to receive approval from the US FDA, replacing its …
gamma release assays (IGRAs) to receive approval from the US FDA, replacing its …
[HTML][HTML] Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with …
Objectives: In this study, we aimed to characterize the SARS-CoV-2-specific T cell response
detected by the QuantiFERON SARS-CoV-2 research use only assay in terms of accuracy …
detected by the QuantiFERON SARS-CoV-2 research use only assay in terms of accuracy …
[HTML][HTML] Analytical evaluation of QuantiFERON-Plus and QuantiFERON-Gold In-tube assays in subjects with or without tuberculosis
Abstract The QuantiFERON-TB Gold Plus (QFT-Plus) represents the new QuantiFERON-TB
Gold In-tube (QFT-GIT) to identify latent tuberculosis infection (LTBI). The main differences is …
Gold In-tube (QFT-GIT) to identify latent tuberculosis infection (LTBI). The main differences is …
QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis
Estimated 2017 tuberculosis (TB) incidence is 10 million and mainly depends on the
reservoir of individuals with latent TB infection (LTBI). QuantiferonⓇ-TB Gold in-Tube (QFT …
reservoir of individuals with latent TB infection (LTBI). QuantiferonⓇ-TB Gold in-Tube (QFT …
Advances in diagnostics and drug discovery against resistant and latent tuberculosis infection
C Shleider Carnero Canales, J Marquez Cazorla… - Pharmaceutics, 2023 - mdpi.com
Latent tuberculosis infection (LTBI) represents a subclinical, asymptomatic mycobacterial
state affecting approximately 25% of the global population. The substantial prevalence of …
state affecting approximately 25% of the global population. The substantial prevalence of …
[HTML][HTML] Managing latent tuberculosis infection and tuberculosis in children
Tuberculosis (TB) is a major cause of childhood morbidity and mortality worldwide. The aim
of this review is to describe the management of the child with TB and latent tuberculosis …
of this review is to describe the management of the child with TB and latent tuberculosis …